HomePharma

Pharma

AstraZeneca Completes Global Licensing Deal for Lung Cancer Drug ZEGFROVY

Life Sciences Times - September 1, 2026

Pharma

Vertex Completes $10 Billion Acquisition of Crinetics, Expands Leadership Team

Life Sciences Times - September 1, 2026

Pharma

Ascletis Doses First Participant in Global Phase 3 Program for Oral GLP-1 Drug ASC30

Life Sciences Times - August 31, 2026

Pharma

Amgen Reports Repatha Reduced Risk of Death in High-Risk Patients Without Prior Heart Attack or Stroke

Life Sciences Times - August 31, 2026

Pharma

Lilly Reports One-Year Phase 3b Data for Taltz and Zepbound in Psoriatic Disease and Obesity

Life Sciences Times - August 31, 2026

Pharma

Q32 Bio Appoints Biopharmaceutical Leader Mark Iwicki as Chairman of Board of Directors

Life Sciences Times - December 22, 2020 0

Pharma

Cecilia Jones Joins LogicBio Therapeutics as Chief Financial Officer

Life Sciences Times - December 22, 2020 0

Pharma

Ajinomoto Bio-Pharma and Revance Therapeutics Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injection

Life Sciences Times - December 22, 2020 0

Pharma

TAGRISSO Approved in the US for the Adjuvant Treatment of Patients With Early-Stage EGFR-mutated Lung Cancer

Life Sciences Times - December 21, 2020 0

Pharma

Servier to Acquire Cambridge-Based Agios Pharmaceuticals’ Oncology Business

Life Sciences Times - December 21, 2020 0

Pharma

Indian pharma companies to benefit from improving US demand: Report

Life Sciences Times - December 19, 2020 0

Pharma

UNICEF to transport up to 850 tons of Covid-19 vaccine per month

Life Sciences Times - December 18, 2020 0

Pharma

India to produce 300 million doses of the Russian Sputnik V vaccine in 2021: Report

Life Sciences Times - December 18, 2020 0

Pharma

Extra Pfizer vaccine doses can be used: FDA tells pharmacists

Life Sciences Times - December 17, 2020 0

Pharma

Moderna Covid vaccine nears approval, FDA confirms safety

Life Sciences Times - December 15, 2020 0

Pharma

Remdesivir may be highly effective against Covid: Study

Life Sciences Times - December 15, 2020 0

Pharma

Agilent Receives Multiple Innovation Awards

Life Sciences Times - December 14, 2020 0

1...979899 Page 98 of 99

Flosonics Medical Partners With BARDA on AI-Enabled Trauma Technology for FloPatch

September 1, 2026

Tobias Janowitz Named Director of Feinstein Institutes’ Cancer Research Institute

September 1, 2026

AstraZeneca Completes Global Licensing Deal for Lung Cancer Drug ZEGFROVY

September 1, 2026

Greater Boston Urology Adds Dr. Akash Sharma and Dr. Rafael Tua-Caraccia

September 1, 2026

Pharma

AstraZeneca Completes Global Licensing Deal for Lung Cancer Drug ZEGFROVY

Vertex Completes $10 Billion Acquisition of Crinetics, Expands Leadership Team

Ascletis Doses First Participant in Global Phase 3 Program for Oral GLP-1 Drug ASC30

Amgen Reports Repatha Reduced Risk of Death in High-Risk Patients Without Prior Heart Attack or Stroke

Lilly Reports One-Year Phase 3b Data for Taltz and Zepbound in Psoriatic Disease and Obesity

Most Read

Flosonics Medical Partners With BARDA on AI-Enabled Trauma Technology for FloPatch

Tobias Janowitz Named Director of Feinstein Institutes’ Cancer Research Institute

AstraZeneca Completes Global Licensing Deal for Lung Cancer Drug ZEGFROVY

Greater Boston Urology Adds Dr. Akash Sharma and Dr. Rafael Tua-Caraccia

EDITOR PICKS

Vertex Completes $10 Billion Acquisition of Crinetics, Expands Leadership Team

FDA Approves PharmaEssentia’s BESREMi for Adults With Essential Thrombocythemia

Agenus Publishes Phase 1b Data on BOT+BAL in Metastatic Colorectal Cancer

THIS WEEK'S STORIES

Karyopharm Submits FDA Application for XPOVIO Combination in Myelofibrosis

TEZSPIRE Meets All Primary and Key Secondary Endpoints in Phase III Eosinophilic Esophagitis Trial

Lilly to Acquire Merida Biosciences in Deal Worth Up to $2.875 Billion

POPULAR CATEGORY

ABOUT US

FOLLOW US